CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Title
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
Authors
Keywords
CD40, CD40L, B lymphocytes, Immunotherapy, Antigen-presenting cell
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 62, Issue 2, Pages 347-357
Publisher
Springer Nature
Online
2012-08-24
DOI
10.1007/s00262-012-1331-4

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started